Tuberculosis and antimicrobial resistance – new models of research and development needed-Reference-Cited by-同舟云学术

Tuberculosis and antimicrobial resistance – new models of research and development needed

Published:2017-05-01 Issue:5 Volume:95 Page:315-315
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:
Short-container-title:Bull. World Health Organ.

Author:

Brigden Grania¹,Castro José Luis¹,Ditiu Lucica²,Gray Glenda³,Hanna Debra⁴,Low Marcus⁵,Matsoso Malebona Precious⁶,Perry Greg⁷,Spigelman Melvin⁸,Swaminathan Souyma⁹,Torreele Els¹⁰,Wong Sidney¹¹

Affiliation:

1. The International Union Against TB and Lung Disease, 68 Boulevard Saint-Michel, 75006, Paris, France.

2. Stop TB Partnership, Geneva, Switzerland.

3. South African Medical Research Council, Cape Town, South Africa.

4. Critical Path Institute, Tucson, United States of America (USA).

5. Global Tuberculosis Community Advisory Board, Cape Town, South Africa.

6. Department of Health, Pretoria, South Africa.

7. Medicines Patent Pool, Geneva, Switzerland.

8. Global Alliance for TB Drug Development, New York, USA.

9. Indian Council of Medical Research, New Delhi, India.

10. Médecins Sans Frontières Access Campaign, Geneva, Switzerland.

11. Médecins Sans Frontières, Amsterdam, Netherlands.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference8 articles.

1. Global tuberculosis report 2016. Geneva: World Health Organization; 2016. Available from: http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1 [cited 2 April 2017].

2. 2016 report on tuberculosis research funding trends, 2005–2015: no time to lose. New York: Treatment Action Group; 2016. Available from: http://www.treatmentactiongroup.org/sites/default/files/TB_FUNDING_2016_WEB.pdf [cited 4 April 2017].

3. Tackling drug-resistant infections globally: final report and recommendations. London: The Review on Antimicrobial Resistance; 2016. Available from: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf [cited 2 April 2017].

4. Research and development to meet health needs in developing countries: strengthening global financing and coordination. Geneva: World Health Organization; 2012. Available from: http://apps.who.int/iris/bitstream/10665/254706/1/9789241503457-eng.pdf?ua=1 [cited 2 April 2017].

5. Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines. New York: United Nations Secretary-General’s High-Level Panel on access to medicines; 2016. Available from: https://static1.squarespace.com/static/562094dee4b0d00c1a3ef761/t/57d9c6ebf5e231b2f02cd3d4/1473890031320/UNSG+HLP+Report+FINAL+12+Sept+2016.pdf [cited 2 April 2017].

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced drug delivery and therapeutic strategies for tuberculosis treatment;Journal of Nanobiotechnology;2023-11-09

2. Developing QSAR Models for the Identification of Inhibitors TargetingMycobacterium tuberculosisEnoyl-ACP Reductase Enzyme;2023-03-15

3. Antibacterial black phosphorus nanosheets for biomedical applications;Journal of Materials Chemistry B;2023

4. Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different;PLOS ONE;2022-07-25

5. A multidimensional approach to the elimination of tuberculosis;Journal of Bacteriology & Mycology: Open Access;2022